|
Name |
2,5-Dimethylpyrazine
|
Molecular Formula | C6H8N2 | |
IUPAC Name* |
2,5-dimethylpyrazine
|
|
SMILES |
CC1=CN=C(C=N1)C
|
|
InChI |
InChI=1S/C6H8N2/c1-5-3-8-6(2)4-7-5/h3-4H,1-2H3
|
|
InChIKey |
LCZUOKDVTBMCMX-UHFFFAOYSA-N
|
|
Synonyms |
2,5-DIMETHYLPYRAZINE; 123-32-0; 2,5-Dimethyl pyrazine; Pyrazine, 2,5-dimethyl-; 2,5-Dimethyl-1,4-diazine; 2,5-Dimethylpiazine; 2,5-Dimethylparadiazine; NSC 49139; FEMA No. 3272; 2,5-Dimethyl-pyrazine; V99Y0MUY1Q; PYRAZINE,2,5-DIMETHYL; CHEBI:89762; MFCD00006147; NSC-49139; CCRIS 2929; 2,5-Dimethylpyrazine (natural); EINECS 204-618-3; UNII-V99Y0MUY1Q; Ketine; AI3-60303; 2.5-dimethylpyrazine; 2, 5-Dimethylpyrazine; pyrazine, 2,5-dimethyl; SCHEMBL82304; 2,5-Dimethylpyrazine, 98%; CHEMBL94709; ZINC3182; DTXSID6047652; FEMA 3272; WLN: T6N DNJ B1 E1; 2,5 and 2,6-dimethyl pyrazine; AMY23196; BCP08618; NSC49139; 2,5-DIMETHYLPYRAZINE [FCC]; 2,5-DIMETHYLPYRAZINE [FHFI]; 2,5-Dimethylpyrazine, >=98%, FG; AKOS003368403; CS-W019957; NCGC00184236-01; NCGC00184236-02; 2,5-Dimethylpyrazine, analytical standard; AC-10703; AS-17251; HY-34439; DB-003236; 2,5-Dimethylpyrazine (contains 2,6-isomer); D1526; D2171; FT-0610477; S3108; EN300-20206; 2,5-dimethylpyrazine and 2,6-dimethylpyrazine; 23D320; P19770; A805045; 2,5-Dimethyl Pyrazine; 2,5-Dimethyl-1,4-diazine; Q-100107; Q27161950; F0001-0364; 25R
|
|
CAS | 123-32-0 | |
PubChem CID | 31252 | |
ChEMBL ID | CHEMBL94709 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 108.14 | ALogp: | 0.6 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 25.8 | Aromatic Rings: | 1 |
Heavy Atoms: | 8 | QED Weighted: | 0.503 |
Caco-2 Permeability: | -4.477 | MDCK Permeability: | 0.00003030 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.004 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.004 |
30% Bioavailability (F30%): | 0.005 |
Blood-Brain-Barrier Penetration (BBB): | 0.719 | Plasma Protein Binding (PPB): | 40.30% |
Volume Distribution (VD): | 1.702 | Fu: | 68.15% |
CYP1A2-inhibitor: | 0.301 | CYP1A2-substrate: | 0.747 |
CYP2C19-inhibitor: | 0.026 | CYP2C19-substrate: | 0.72 |
CYP2C9-inhibitor: | 0.003 | CYP2C9-substrate: | 0.441 |
CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.822 |
CYP3A4-inhibitor: | 0.008 | CYP3A4-substrate: | 0.265 |
Clearance (CL): | 7.66 | Half-life (T1/2): | 0.383 |
hERG Blockers: | 0.011 | Human Hepatotoxicity (H-HT): | 0.549 |
Drug-inuced Liver Injury (DILI): | 0.306 | AMES Toxicity: | 0.025 |
Rat Oral Acute Toxicity: | 0.166 | Maximum Recommended Daily Dose: | 0.036 |
Skin Sensitization: | 0.832 | Carcinogencity: | 0.631 |
Eye Corrosion: | 0.938 | Eye Irritation: | 0.991 |
Respiratory Toxicity: | 0.732 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000240 | 0.333 | D02NJA | 0.219 | ||||
ENC002316 | 0.324 | D0S1NZ | 0.214 | ||||
ENC000577 | 0.306 | D0U2CV | 0.208 | ||||
ENC000657 | 0.281 | D09MGR | 0.203 | ||||
ENC002253 | 0.259 | D06PQT | 0.200 | ||||
ENC000650 | 0.238 | D0V9YR | 0.194 | ||||
ENC000092 | 0.231 | D02LDV | 0.194 | ||||
ENC000239 | 0.222 | D0V5IW | 0.191 | ||||
ENC000233 | 0.222 | D08IBS | 0.186 | ||||
ENC000179 | 0.222 | D04KYY | 0.186 |